市場調査レポート

商品コード

1623791

胆嚢治療の市場規模、シェア、成長分析、疾患適応症別、治療タイプ別、エンドユーザー別、地域別 - 産業予測、2025～2032年

Gallbladder Treatment Market Size, Share, Growth Analysis, By Disease indications (Gallstones, Cholecystitis & Biliary Colic), By Treatment Type (Surgery, Drugs), By End- User, By Region - Industry Forecast 2025-2032

出版日: 2024年12月26日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 779,047円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 911,338円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,043,629円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
目次

概要

サンプル依頼リストに入れる

胆嚢治療の世界市場規模は2023年に176億3,000万米ドルと評価され、2024年の191億8,000万米ドルから2032年には376億6,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは8.8％で成長する見通しです。

世界の胆嚢治療市場は、不健康なライフスタイル、肥満、遺伝的要因によって悪化した胆石や胆嚢炎などの胆嚢疾患の有病率の上昇によって成長を遂げています。患者数の増加は、外科的介入や革新的な薬物療法を含む様々な治療オプションに対する需要を促進します。技術の進歩、特に腹腔鏡下胆嚢摘出術のような低侵襲技術は、手技の安全性と有効性を高め、市場拡大に寄与しています。しかし、特にヘルスケアへのアクセスが限られている地域では治療費が高く、患者の治療が遅れるという課題が残っています。治療の安全性に対する懸念や高度医療へのアクセスにおけるばらつきが、市場力学をさらに複雑にしています。効果的な胆嚢治療への患者のアクセスを最適化するためには、多様な規制の枠組みや償還政策をうまく利用することが重要です。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
収益の前年比比較（2022-2024）

主要企業プロファイル

Medtronic
Stryker Corporation
Johnson & Johnson
Boston Scientific Corporation
Cook Medical LLC
Abbott Laboratories
Olympus Corporation
F. Hoffmann-La Roche Ltd
Pfizer Inc.
Merck & Co.
B. Braun Melsungen AG
Intuitive Surgical
Baxter International
GE Healthcare
Siemens Healthineers

結論と推奨事項

Product Code: SQMIG35D2258

Global Gallbladder Treatment Market size was valued at USD 17.63 billion in 2023 and is poised to grow from USD 19.18 billion in 2024 to USD 37.66 billion by 2032, growing at a CAGR of 8.8% during the forecast period (2025-2032).

The global gallbladder treatment market is experiencing growth driven by the rising prevalence of gallbladder disorders such as gallstones and cholecystitis, exacerbated by unhealthy lifestyles, obesity, and genetic factors. An increasing patient population fosters demand for various treatment options, including surgical interventions and innovative pharmacological therapies. Technological advancements, particularly in minimally invasive techniques like laparoscopic cholecystectomy, enhance procedural safety and efficacy, contributing to market expansion. However, challenges remain due to high treatment costs, especially in regions with limited healthcare access, which can delay patient care. Concerns over treatment safety and variability in access to advanced care further complicate market dynamics. Navigating diverse regulatory frameworks and reimbursement policies is critical for optimizing patient access to effective gallbladder treatments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gallbladder Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gallbladder Treatment Market Segmental Analysis

Global Gallbladder Treatment Market is segmented by product type, diagnosis, treatment, end user and region. Based on product type, the market is segmented into gallstones, cholecystitis & biliary colic, cholelithiasis & choledocholithiasis and gall bladder cancer. Based on diagnosis, the market is segmented into ultrasound, blood tests, computerized tomography, cholangiography and hepatobiliary scintigraphy. Based on treatment, the market is segmented into surgery and drugs. Based on end user, the market is segmented into hospitals, gynecology clinics, academic, research centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Gallbladder Treatment Market

The global gallbladder treatment market is propelled by several key factors, notably the rising prevalence of gallbladder disorders, including gallstones, cholecystitis, and gallbladder cancer. This increase can be attributed to various contributors such as obesity, unhealthy eating habits, sedentary lifestyles, and genetic factors, all of which intensify the global demand for effective treatment solutions. Furthermore, advancements in medical technology have significantly transformed the landscape of gallbladder disorder management, introducing minimally invasive techniques like laparoscopic cholecystectomy that enhance patient outcomes by shortening recovery times and reducing pain. Additionally, improvements in imaging technologies, endoscopic procedures, and pharmaceutical therapies have broadened the treatment spectrum and enhanced effectiveness for patients.

Restraints in the Global Gallbladder Treatment Market

The Global Gallbladder Treatment market faces significant restraints that can impede growth and accessibility. One major concern is the high cost of treatment, which encompasses surgical procedures, medications, and diagnostic tests; such expenses can be prohibitive for individuals lacking adequate health insurance. As a result, many patients may postpone seeking necessary medical care or may choose less effective treatment alternatives, contributing to delayed diagnoses and potentially worsening health outcomes. Additionally, limited access to healthcare services, especially in rural or underserved communities, complicates the situation further. The scarcity of specialized surgical expertise and necessary diagnostic equipment can create disparities in care, particularly among marginalized groups, exacerbating delays in diagnosis and treatment management for gallbladder disorders.

Market Trends of the Global Gallbladder Treatment Market

The Global Gallbladder Treatment market is witnessing a notable trend towards early detection and prevention strategies aimed at managing gallbladder disorders. As healthcare professionals increasingly prioritize screening programs and risk assessments, there is a heightened focus on identifying high-risk individuals-particularly those with obesity, metabolic syndrome, or a family history of gallstones. This proactive approach facilitates timely interventions and encourages lifestyle modifications that mitigate the development of gallbladder diseases. Consequently, this trend not only enhances patient outcomes but also significantly decreases healthcare expenditures related to the management of advanced gallbladder conditions, marking a pivotal shift in treatment paradigms.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis

Global Gallbladder Treatment Market Size by Product Type & CAGR (2025-2032)

Market Overview
Gallstones
Cholecystitis & Biliary Colic
Cholelithiasis & Choledocholithiasis
Gall Bladder Cancer

Global Gallbladder Treatment Market Size by Diagnosis & CAGR (2025-2032)

Market Overview
Ultrasound
Blood Tests
Computerized Tomography
Cholangiography
Hepatobiliary Scintigraphy

Global Gallbladder Treatment Market Size by Treatment & CAGR (2025-2032)

Market Overview
Surgery
Drugs

Global Gallbladder Treatment Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals
Gynecology Clinics
Academic
Research Centers
Others

Global Gallbladder Treatment Market Size & CAGR (2025-2032)

North America (Product Type, Diagnosis, Treatment, End User)
- US
- Canada
Europe (Product Type, Diagnosis, Treatment, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Diagnosis, Treatment, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Diagnosis, Treatment, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Diagnosis, Treatment, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intuitive Surgical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

胆嚢治療の市場規模、シェア、成長分析、疾患適応症別、治療タイプ別、エンドユーザー別、地域別 - 産業予測、2025～2032年

Gallbladder Treatment Market Size, Share, Growth Analysis, By Disease indications (Gallstones, Cholecystitis & Biliary Colic), By Treatment Type (Surgery, Drugs), By End- User, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

胆嚢治療市場規模：疾患適応症別

胆嚢治療市場規模：診断別

胆嚢治療市場規模：治療別

胆嚢治療市場規模：エンドユーザー別

胆嚢治療市場規模